Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
3.370
+0.025 (0.75%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pluri Employees
As of June 30, 2025, Pluri had 142 total employees, including 127 full-time and 15 part-time employees. The number of employees increased by 24 or 20.34% compared to the previous year.
Employees
142
Change (1Y)
24
Growth (1Y)
20.34%
Revenue / Employee
$9,430
Profits / Employee
-$184,070
Market Cap
33.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Senti Biosciences | 34 |
| Palatin Technologies | 29 |
| Boundless Bio | 28 |
| Tevogen Bio Holdings | 18 |
| Outlook Therapeutics | 17 |
PLUR News
- 4 months ago - Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved - GlobeNewsWire
- 1 year ago - BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials - PRNewsWire
- 1 year ago - Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd. - GlobeNewsWire
- 1 year ago - Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness - GlobeNewsWire
- 1 year ago - Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution - GlobeNewsWire
- 1 year ago - Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - GlobeNewsWire
- 1 year ago - Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease - GlobeNewsWire
- 1 year ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire